RxDoctor Payments DataLook up a doctor →

Matthew Ohr, MD

Retina Specialist · Columbus, OHNPI 1023199841

Payments from drug & device makers

$2,394,504in general payments, 2019–2025

Across 292 payments — averaging $8200.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$1.9M
  • Apellis Pharmaceuticals, Inc.$224K
  • Novartis$177K
  • Regeneron$85K
  • AbbVie$7K
  • Alcon$19
$3,451in research payments, 2019–2025

Across 16 payments — averaging $215.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$3K

General payments by program year

19
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.239$1,901,886
Apellis Pharmaceuticals, Inc.29$224,037
Novartis3$177,434
Regeneron19$84,628
AbbVie1$6,500
Alcon1$19

How this compares

$2,394,504 in reported general payments places this provider in the 95th percentile of 69 retina specialist providers in Ohio.

See all retina specialist providers in Ohio

Medicare billing

Part B allowed, 2024
$246,232
Medicare patients
560
Services billed
8,045

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other retina specialist in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →